Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort
- Conditions
- Acute Myocardial InfarctionAdverse Event
- Interventions
- Other: Treatment Strategies
- Registration Number
- NCT05862103
- Lead Sponsor
- Yu Bo
- Brief Summary
AMI Survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 15000
- AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit.
- Telephone to obtain informed consent from the subjects/family members of the subjects.
- Not available
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description optimized group Treatment Strategies the patients received at least one optimized treatment
- Primary Outcome Measures
Name Time Method Incidence of MACCE 5 years after discharge the incidence of MACCE (death, heart failure, rehospitalization, re-myocardial infarction, re-myocardial revascularization, stroke, malignant arrhythmia, bleeding events, etc.) in AMI patients
- Secondary Outcome Measures
Name Time Method Differences of MACCE between defer PCI group and direct PCI group 3 and 5 years after discharge Differences of MACCE between defer PCI group and direct PCI group
Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group 5 years after discharge Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group
Differences of the MACCE between OCT-guided group and the coronary angiography -guided group 5 years after discharge Differences of the MACCE between OCT-guided group and the coronary angiography -guided group
Differences of MACCE between the optimized group and the non-optimized group 5 years after discharge Differences of the MACCE between the optimized group and the non-optimized group
Trial Locations
- Locations (18)
Beijing An Zhen Hospital, Capital Medical University
π¨π³Beijing, Beijing, China
Beijing Chao-Yang Hospital, Capital Medical University
π¨π³Beijing, Beijing, China
Guangdong general hospital
π¨π³Guangzhou, Guangdong, China
The First Affiliated Hospital of Zhengzhou University
π¨π³Zhengzhou, Henan, China
The first affiliated hospital of Guangxi medical university
π¨π³Nanning, Guangxi, China
Second hospital of hebei medical university
π¨π³Shijiazhuang, Hebei, China
Daqing Oil Field Hospital
π¨π³Daqing, Heilongjiang, China
The Second Hospital of Jilin University
π¨π³Changchun, Jilin, China
Zhongda Hospital Southeast University
π¨π³Nanjing, Jiangsu, China
The Second Affiliated Hospital of Nanchang University
π¨π³Nanchang, Jiangxi, China
The econd Affiliated Hospital of Dalian Medical University
π¨π³Dalian, Liaoning, China
General Hospital of Northern Theater Command of the Chinese People's Liberation Army
π¨π³Shenyang, Liaoning, China
Xijing Hospital of Air Force Military Medical University
π¨π³Xi'an, Shanxi, China
Xinqiao Hospital Army Medical University
π¨π³Chongqing, Sichuan, China
Tianjin Chest Hospital
π¨π³Tianjing, Tianjin, China
The General Hospital of Tianjin Medical University
π¨π³Tianjin, Tianjin, China
First Affiliated Hospital of Xinjiang Medical University
π¨π³ΓrΓΌmqi, Xinjiang, China
Peking University First Hospital
π¨π³Beijing, Beijing, China